No Picture
News

IDEAYA to Participate in Fireside Chat at BTIG Biotechnology Conference and Wedbush PacGrow Healthcare Conference on August 11 and 12, 2020

SOUTH SAN FRANCISCO, Calif., July 14, 2020 /PRNewswire/ — IDEAYA Biosciences, Inc. (Nasdaq: IDYA), an oncology-focused precision medicine company committed to the discovery and development of targeted therapeutics, announced the Company will parti… […]

No Picture
News

Kodiak Sciences Announces New Longer-Term Safety, Efficacy and Durability Data from Ongoing Phase 1b Study of KSI-301 in Patients with Wet Age-Related Macular Degeneration, Diabetic Macular Edema and Retinal Vein Occlusion at the American Society of Retina Specialists (ASRS) 2020 Virtual Annual Meeting

– Strong anti-VEGF safety, efficacy and durability continue to be observed across all three of the major retinal vascular diseases, with most patients achieving treatment-free intervals of 6-months in wet AMD, 6-months or longer in DME, and 4-months o… […]

No Picture
News

IDEAYA Biosciences Doses First Patient in a Phase 1 Combination Study of IDE196 and Binimetinib, a MEK Inhibitor

SOUTH SAN FRANCISCO, Calif., July 9, 2020 /PRNewswire/ — IDEAYA Biosciences, Inc. (NASDAQ:IDYA), an oncology-focused precision medicine company committed to the discovery and development of targeted therapeutics, announced First-Patient-In (FPI) in… […]

No Picture
News

ValGenesis VLMS to Digitize Validation Lifecycle Processes for Fast Growing Biopharmaceutical Company

SAN FRANCISCO, July 8, 2020 /PRNewswire/ — ValGenesis, Inc., a market leader in Enterprise Validation Lifecycle Management solutions, today announced that a fast growing research based biopharmaceutical company has chosen the ValGenesis Validation … […]

No Picture
News

Kodiak Sciences Announces Upcoming Presentation of KSI-301 Clinical Study Data at American Society of Retina Specialists (ASRS) 2020 Virtual Annual Meeting and R&D Webinar

PALO ALTO, Calif., July 7, 2020 /PRNewswire/ — Kodiak Sciences Inc. (Nasdaq: KOD), a clinical stage biopharmaceutical company specializing in novel therapeutics to treat chronic, high-prevalence retinal diseases, today announced that new data from … […]

No Picture
News

IDEAYA Appoints Garret Hampton, Ph.D., to the Board of Directors, an Industry Leader in Precision Medicine Oncology and Diagnostics

– Dr. Garret Hampton serves as President, Clinical Sequencing and Oncology at Thermo Fisher Scientific, and held leadership roles at Illumina and Genentech

SOUTH SAN FRANCISCO, Calif., June 30, 2020 /PRNewswire/ — IDEAYA Biosciences, Inc. (NASDAQ:… […]

No Picture
News

Eurofins DiscoverX Further Expands Its Bioassay Certification Program with Catalent Biologics

Eurofins DiscoverX announces Catalent Biologics as a North American Certified Biologics Analytical Laboratory

FREMONT, Calif., June 29, 2020 /PRNewswire/ — Eurofins DiscoverX, the products company of Eurofins Discovery, today announced the expansio… […]